All Blogs / Industries / Medical / Pharmaceutical / New

In Honor of the late Dr. David Thorley-Lawson

Samuel H. Speck, PLOS Pathogens Section Editor, and Alexander Poltorak, Associate Professor at Tufts University, remember their friend and colleague David Thorley-Lawson, and reflect on his contributions to the understanding of Epstein-Barr virus. Epstein-Barr virus

2016’s Top Retail Pharmacy Chains, According to Drug Store News

Drug Store News (DSN) has just released its latest rundown of the top pharmacy retailers in the mightily-titled PoweRx 50. (Links below.) I recommend the PoweRx list to anyone who competes with, sells to, or otherwise interacts with retail pharmacy chains. Show More Summary

PLOS Medicine Special Issue: Cardiovascular disease and multimorbidity

The editors of PLOS Medicine together with guest editors Carolyn S. P. Lam, Kazem Rahimi, and Steven Steinhubl are delighted to announce a forthcoming special issue focused on cardiovascular disease and multimorbidity. Research submissions are

Understanding CMS’s Surprising Reimbursement Cut for 340B Hospitals

Last Thursday, the Centers for Medicare & Medicaid Services (CMS) shocked everyone with a proposal altering a small part of the 340B Drug Pricing Program. CMS proposed reducing reimbursement for certain Medicare Part B drugs purchased by 340B-eligible hospitals: from Average Sales Price (ASP) plus 6% to ASP minus 22.5%. Show More Summary

CBI’s Life Sciences Outcomes-Based Contracting Summit

CBI’s Life Sciences Outcomes-Based Contracting SummitOctober 3-4, 2017 | Philadelphia, Exclusive Offer for Drug Channels Readers:Register Now to SAVE $400 using promo code DCR400 Hurry! This Offer Expires August 14, 2017. Show More Summary

10 Hospitals With 340B Contract Pharmacy Mega-Networks

For a follow-up to The Booming 340B Contract Pharmacy Profits of Walgreens, CVS, Rite Aid, and Walmart, let’s examine covered entities’ contract pharmacy networks in the 340B Drug Pricing Program. Many covered entities have relatively small 340B contract pharmacy networks. Show More Summary

The Booming 340B Contract Pharmacy Profits of Walgreens, CVS, Rite Aid, and Walmart

Pharmacies continue to ride the 340B Drug Pricing Program’s explosive growth. Our latest exclusive analysis finds that nearly 20,000 pharmacy locations now act as a contract pharmacy for the hospitals and other healthcare providers that participate in the 340B Program. Show More Summary

Medicaid Drug Rebate Program Summit 2017

Medicaid Drug Rebate Program Summit 2017September 11-13, 2017Marriott Magnificent Mile | Drug Rebate Program Summit 2017 is a platform to: Network with 600+ government officials, industry leaders,...Show More Summary

What I Told HHS Secretary Tom Price About the 340B Drug Pricing Program (rerun)

This week, I’m rerunning some popular posts while I'm on vacation. Click here to see the original post and comments from May 2017. This post is especially timely given President Trump’s draft Executive Order. In Section 4, the OrderShow More Summary

What They Said – 2nd Quarter 2017

During a somewhat slow week given the holiday that coincides with the end of the second quarter, this is a good time to look back at press releases for the quarter and the year so far. A single press release … Continue reading ?

Is FDA Too Slow to Approve New Drugs?

Back in March, 2017, President Trump "called on the Food and Drug Administration to speed the approval of drugs to treat life-threatening diseases, deriding the agency’s current process as 'slow and burdensome'”(here). According to Dr. Show More Summary

Cardinal Health’s Unhappy Profit Surprise: The Coevolution of Pharmacy Buying Groups and Wholesaler Economics (rerun)

This week, I’m rerunning some popular posts while I'm on vacation. Click here to see the original post and comments from April 2017. Yesterday probably didn’t turn out as well as Cardinal Health had expected. The good news: The company...Show More Summary

A PLOS Medicine Special Issue: Trauma

An overview of the first week of the PLOS Medicine Trauma Special Issue This month, PLOS Medicine is proud to present our Special Issue on Traumatic Injury. Guest Editors Professor Karim Brohi (Queen Mary University of London)

Eliminating Lymphatic Filariasis in Cameroon

PLOS NTDs Editors-in-Chief Peter Hotez and Serap Aksoy discuss new research and the global effort towards eliminating lymphatic filariasis. One of the most significant, yet often unheralded, accomplishments from the 2000-2015 Millennium Development Goals (MDGs)

Five Fun Facts About the New Express Scripts-GoodRx Drug Discount Partnership (rerun)

This week, I’m rerunning some popular posts while I'm on vacation. Click here to see the original post and comments from May 2017. Last week, the pharmacy benefit manager (PBM) Express Scripts and the online discount card company GoodRx partnered on a new program called Inside Rx. Show More Summary

Partnering with IDNs BioPharma Strategy Summit

Partnering with IDNs BioPharma Strategy SummitAugust 16-17, 2017 | Philadelphia, health systems continue to grow and consolidate to form major Integrated Delivery Networks (IDNs), manufacturers are tasked...Show More Summary

Observations on the New Walgreens Boots Alliance-Rite Aid Deal

Yesterday we got some pre—July 4th fireworks. Walgreens Boots Alliance (WBA) announced a deal to buy 2,186 Rite Aid stores and three distribution centers for $5.2 billion. Rite Aid will also get the option to source generic drugs via the wonderfully named Walgreens Boots Alliance Development (WBAD) organization. Show More Summary

The Forgotten eHealth Code of Ethics

Recently, I was sorry to see that the eHealth Code of Ethics, which I helped create back in 2000, was not included in the list of references to an article about trust and credibility of web-based health information. According to theShow More Summary

Drug Channels News Roundup, June 2017: Amazon, Whole Foods, 340B, DIR Fees, Provider-Sponsored Health Plans, and Kaiser

Happy 241st birthday, America! Before you launch your July 4 festivities, please enjoy these Drug Channels fireworks: My $0.02 on how Amazon-Whole Foods affects Amazon’s pharmacy ambitions Congress starts to get serious about the 340B...Show More Summary

CBI’s 9th Hub and SPP Model Optimization

CBI’s 9th Hub and SPP Model OptimizationSeptember 26-27, 2017 | San Diego, all manufacturers, specialty pharmacies, PBMs and hub service providers!Head to San Diego this September to discuss the opportunities and challenges for swiftly moving data among all stakeholders to improve patient access and hub performance. Show More Summary

Copyright © 2015 Regator, LLC